Table 1 Basic patient information.

From: Pharmacovigilance evidence of drug induced urinary incontinence in the FDA adverse event reporting system

Characteristics

Numbers

Proportion (%)

Drug-induced UI

19,653

 

Gender

  

 Male

6469

32.92%

 Female

11,833

60.21%

 Miss

1351

6.87%

Age

  

 Median (Q1, Q3)

62 (47,73)

 

 Miss

5913

30.1%

Weight

  

 Median (Q1, Q3)

73 (61,89)

 

 Miss

11,936

60.73%

Top 5 reporting countries

 

 United States

10,569

53.78%

 United Kingdom

1600

8.14%

 Canada

963

4.9%

 Germany

732

3.72%

 France

599

3.05%

Reporter

  

 Healthcare professional

9951

50.63%

 Non-healthcare professional

8393

42.71%

 Miss

1309

6.66%

Outcomes

  

 Hospitalization

6467

32.91%

 Death

1206

6.14%

 Disability

705

3.59%

 Life-Threatening

939

4.78%

 Required Intervention

67

0.34%

 Congenital Anomaly

32

0.16%

 Other Serious

6462

32.88%

 Miss

3775

19.21%

  1. UI urinary incontinence, Q1 first quartile, Q3 third quartile.